Aurobindo Pharma Limited
AUROPHARMANSE•Healthcare
Previous Close
₹1,247.50
Last Updated
20 Mar, 07:18 am
Market Cap
N/A
P/E Ratio
21.481667
52W High
₹1,319.80
52W Low
₹1,010.00
Open
₹1,255.00
High
₹1,269.00
Low
₹1,240.00
Volume
5,93,069
Price Chart with Technical Indicators
• Blue line: Stock price
• Yellow dashed line: 20-day moving average
• Red dashed line: 50-day moving average
• Gray line: Trading volume (scaled for visualization)
Performance Analysis
52W Range Position
90.0%
Above midpoint
From 52W High
2.3%
From 52W Low
+27.6%
Average Price
₹1247.50
Trading Metrics
Volume
5,93,069
Avg Volume
8,16,613
Volume Ratio
0.73x
Normal
Volatility
N/A
Moderate
Financial Fundamentals
Profit
₹0.00 Cr
Debt
₹0.00 Cr
Risk Assessment
Price Stability
Volatile
Market Position
Strong
Liquidity
Moderate
Valuation Metrics
P/E Ratio
21.481667
Fair value
About Aurobindo Pharma Limited
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Latest News
No news available for this stock.